JPRN-UMIN000021036招募中未知
Effects of nintedanib in idiopathic pulmonary fibrosis - analysis on long term prognosis and predictive factors - - Effects of nintedanib in idiopathic pulmonary fibrosis
ational Hospital Organization Tokyo Medical Center, Department of Respiratory Medicine0 个研究点目标入组 100 人开始时间: 2016年2月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Cases with severe liver, renal or metabolic dysfunction. 2. Complicated by malignancy. 3. Any other cases that the attending physician considers to be inappropriate.
研究者
相似试验
招募中
不适用
Intrapulmonal nintedanib distribution in fibrotic interstitial lung disease patients: drug concentrations in lung explantatesInterstitial lung diseaseNL-OMON21428Erasmus MC dept. of Medical Oncology and dept. of Pulmonology10
已完成
不适用
Efficacy of imatinib for the treatment of pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosispulmonary veno-occlusive disease/pulmonary capillary hemangiomatosisJPRN-UMIN000020543ational Hospital Organization Okayama Medical Center8
招募中
不适用
Efficacy and Safety of Nintedanib in Idiopathic Pleuroparenchymal Fibroelastosis (Phase 2 trial)Idiopathic pleuroparenchymal fibroelastosisJPRN-UMIN000042946Department of Respiratory Medicine and Rheumatology Graduate School of Biomedical Sciences Tokushima University10
招募中
不适用
Idiopathic Pulmonary Fibrosis treated with Anti-fibrotic Drugs Prospective Observational TrialIdiopathic pulmonary fibrosisJPRN-UMIN000019826HO Kinki-Chuo Chest Medical Center100
尚未招募
不适用
The effect of Nintedanib in post-COVID-19 lung fibrosis: an observational studyPatients with COVID-19 pneumonia and lung fibrosisCOVID-19Lung fibrosisNintedanibAntifibroticOxygenationChest radiographMortalityPneumoniaTCTR20220426001Faculty of Medicine, Thammasat University29